$CTMX Cashflow Statement | Understand Stock

$CTMX

$2.31 +$0.08 (3.82%) Close

$CTMX Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Statements of cash flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Net income (loss)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Amortization of intangible assets
Depreciation and amortization
Impairment loss on machinery and equipment
Accretion of discounts on short-term investments
Stock-based compensation expense
Non-cash lease expense
Issuance of common stock in connection with UCSB sublicense fee
Changes in operating assets and liabilities
Accounts receivable
Prepaid expenses and other assets
Other assets
Accounts payable
Accrued liabilities, income tax payable and other long-term liabilities
Accrued liabilities and other long-term liabilities
Deferred revenue

Net cash used in operating activities
Cash flows from investing activities:
Purchases of property and equipment
Purchases of investments
Maturities of investments
Purchases of short term investments
Maturities of short term investments
Net cash provided by (used in) investing activities

Cash flows from financing activities:
Proceeds from issuance of pre-funded warrants and warrants, net of issuance cost
Proceeds from issuance of common stock, net of issuance cost
Proceeds from employee stock purchase plan and exercise of stock options
Net cash provided by financing activities
Net increase (decrease) in cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash, beginning of year
Cash, cash equivalents and restricted cash, end of year
Cash paid for income taxes
Supplemental disclosures of noncash investing items:
Purchases of property and equipment in accounts payable and accrued liabilities
Right of use assets obtained in exchange for operating lease obligations

Supplemental disclosures of noncash financing items:
Deemed dividend on warrants

Comments